Publication Count – 2012


None reported


  1. Hepatocellular carcinoma in sub-Saharan Africa. M.C. Kew. Published by Trafford Publishers, India , USA. 2012.

Chapters in Books

  1. Barnes, K.I. 2012. Antimalarial drugs and the control and elimination of malaria. In H.M Staines and S. Krishna (eds), Treatment and Prevention of Malaria: Antimalarial Drug Chemistry, Action and Use, pp. 1-17. London: Springer Science & Business Media B.V. ISBN 9873034604796.
  2. Bekker, L., Beyrer, C. and Quinn, T. 2012. Behavioral and Biomedical combination strategies for HIV Prevention. In F. Bushman, G. Nabel, and R. Swanstrom (eds), HIV:  From biology to prevention and treatment, pp. 537-559. New York: Cold Spring Harbor Lab Press. ISBN 9781936113408.
  3. Blumberg, L., Cohen, C. and Barnes, K.I. 2012. Malaria. In M. Kibel, H. Saloojee and T. Westwood (eds), Child Health for All, pp. 404-411. 5th edition. Cape Town: Oxford University Press Southern Africa. ISBN 9780199042357.
  4. Wearne N. HIV Associated Nephropathy: Kumar and Clarke’s Clinical Medicine 8th Edition, Kumar P, Clarke M (eds), Elsevier, 2012. ISBN-9780702044991.

Peer-reviewed Journals (DoE Accredited)

  • A - E

    1. Ahonkhai, A.A., Noubary, F., Munro, A., Stark, R., Wilke, M., Freedberg, K.A., Wood, R. and Losina, E. 2012. Not all are lost: interrupted laboratory monitoring early death, and loss to follow-up (LTFU) in a large South African treatment program. PLoS One, 7(3): e32993.
    1. Airoldi, F., Faglia, E., Clerici, G. and Latib, A. 2012. Bailout directional atherectomy for side branch salvage following subintimal recanalization of infragenicular arteries. Vasa-European Journal of Vascular Medicine, 41: 292-294.
    1. Akinyi, M., Dandara, C., Gamieldien, J. and Heckmann, J.M. 2012. Association of transforming growth factor beta-1 (TGFB1) regulatory region polymorphisms with myasthenia gravis-related ophthalmoparesis. Journal of Neuroimmunology, 246: 96-99.
    1. Alvarez, G.G., Sabri, E., Ling, D., Cameron, D.W., Maartens, G. and Wilson, D. 2012. A model to rule out smear-negative tuberculosis among symptomatic HIV patients using C-reactive protein. International Journal of Tuberculosis and Lung Disease, 16(9): 1247-1251.
    1. Aminake, M.N., Mahajan, A., Kumar, V., Hans, R.H., Wiesner, L., Taylor, D., De Kock, C., Grobler, A., Smith, P.J., Kirschner, M., Rethwilm, A., Pradel, G. and Chibale, K. 2012. Synthesis and evaluation of hybrid drugs for a potential HIV/AIDS-malaria combination therapy. Bioorganic & Medicinal Chemistry, 20: 5277-5289.
    1. Anderson, P.L., Glidden, D.V., Liu, A., Buchbinder, S.P., Lama, J.R., Guanira, J.V., McMahan, V., Bushman, L.R., Casapia, M., Montoya-Herrera, O., Veloso, V.G., Mayer, K.H., Chariyalertsak, S., Schechter, M., Bekker, L., Kallas, E.G. and Grant, R. 2012. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Science Translational Medicine, 4(151): 1-8.
    1. Andrews, J.R., Wood, R., Bekker, L., Middelkoop, K. and Walensky, R.P. 2012. Projecting the benefits of antiretroviral therapy for HIV prevention: the impact of population mobility and linkage to care. Journal of Infectious Diseases, 206: 543-551.
    1. Andrews, J.R., Lawn, S.D., Rusu, C., Wood, R., Noubary, F., Bender, M., Horsburgh, C.R., Losina, E., Freedberg, K.A. and Walensky, R.P. 2012. The cost-effectiveness of routinne tuberculosis screening with xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis. AIDS, 26: 987-995.
    1. Arentz, M., Pavlinac, P., Kimerling, M.E., Horne, D.J., Falzone, D., Schunemann, H.J., Royce, S., Dheda, K. and Walson, J.L. 2012. Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review. PLoS One, 7(11): e47370.
    1. Ataher, Q., Portsmouth, S., Napolitano, L., Eng, S., Greenacre, A., Kambugu, A., Wood, R., Badal-Faesen, S. and Tressler, R. 2012. The epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South Africa. Journal of the International AIDS Society, 15:2.
    1. Bateman, E.D., Bleecker, E.R., Lotvall, J., Woodcock, A., Forth, R., Medley, H., Davis, A.M., Jacques, L., Haumann, B. and Busse, W. 2012. Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial. Respiratory Medicine, 106: 642-650.
    1. Bateman, E.D., Feldman, G., Kilbride, S., Brooks, J., Mehta, R., Harris, S., Maden, C. and Crater, G. 2012. Efficacy and safety of the long-acting muscarinic antagonist GSK233705 delivered once daily in patients with COPD. Clinical Respiratory Journal, 6: 248-257.
    1. Beach, R.A., Wilkinson, K., Gumedze, F.N. and Khumalo, N. 2012. Baseline sebum 1L-1& is higher than expected in afro-textured hair: a risk factor for hair loss?. Journal of Cosmetic Dermatology, 11: 9-16.
    1. Beach, R.A., Wilkinson, K., Gumedze, F.N. and Khumalo, N.P. 2012. Sebum transforming growth factor B1 induced by Hair Products. Archives of Dermatology, 148(6): 764-766.
    1. Benatar, S.R. and Benatar, D. 2012. From medical manners to moral reasoning: an historical overview of bioethics in the University of Cape Town's Faculty of Health Sciences. SAMJ South African Medical Journal, 102(6): 406-408.
    1. Benjamin, L.A., Bryer, A., Emsley, H.C.A., Khoo, S., Solomon, T. and Connor, M.D. 2012. HIV infection and stroke: current perspectives and future directions. Lancet Neurology, 11: 878-890.
    1. Bertram, M.Y., Steyn, K., Wentzel-Viljoen, E., Tollman, S.M. and Hofman, K.J. 2012. Reducing the sodium content of high-salt foods: effect on cardiovascular disease in South Africa. SAMJ South African Medical Journal, 102(9): 743-745.
    1. Besana, A., Wang, D.W., George Jr, A.L. and Schwartz, P.J. 2012. Nadolol block of nav1.5 does not explain its efficacy in the long QT syndrome. Journal of Cardiovascular Pharmacology, 59(3): 249-253.
    1. Black, J.M., Kruger, R., Roberts, R., Lehloenya, R. and Mendelson, M. 2012. Acute generalised exanthematous pustulosis secondary to cotrimoxazole or tenofovir. Southern African Journal of HIV medicine, 13(4): 198-200.
    1. Bleecker, E., Bateman, E.D., Busse, W., Woodcock, A., Frith, L., House, K.W., Jacques, L., Davis, A.M., Haumann, B. and Lotvall, J. 2012. Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids. Annals of Allergy Asthma & Immunology, 109(5): 353-358.
    1. Blom, D. 2012. Statin therapy for the octogenarian? Journal of Endocrinology, Metabolism and Diabetes of South Africa (JEMDSA), 17(1): 37-42.
    1. Bloom, C., Graham, C.M., Berry, M.P.R., Wilkinson, K., Oni, T., Rozakeas, F., Xu, Z., Rossello-Urgell, J., Chaussabel, D., Banchereau, J., Pascual, V., Lipman, C.I., Wilkinson, R.J. and O' Garra, A. 2012. Detectable changes in the bloodtransriptome are present after two weeks of antituberculosis therapy. PLoS One, 7(10): e46191.
    1. Bond, E., Liang, F., Sandgrem, K.J., Smed-Sorensen, A., Bergman, P., Brighenti, S., Adams, W., Betemariam, S.A., Rangaka, M.X., Lange, C., Wilkinson, R.J., Andersson, J. and Lore, K. 2012. Plasmacytoid dendritic cells infiltrate the skin in positive tuberculin skin test indurations. Journal of Investigative Dermatology, 132: 114-123.
    1. Booysen, H.L., Norton, G., Opie, L.H. and Woodiwiss, A. 2012. Reverse chamber remodelling following adrenergic-induced advanced cardiac dilatation and pump dysfunction. Basic Research in Cardiology, 107(238).
    1. Boulet, L.-P., FitzGerald, J.M., Levy, M.L., Cruz, A.A., Pedersen, S., Haahtela, T. and Bateman, E.D. 2012. A guide to the translation of global initiative for asthma (GINA) strategy into improved care. European Respiratory Journal, 39(5): 1220-1229.
    1. Bousquet, J., Anto, J.M., Demoly, P., … Bateman, E.D.,... Zar, H.J. et al. 2012. Severe Chronic Allergic (and Related) Diseases: A Uniform Approach - A MeDALL - GA LEN - ARIA Position Paper. International Archives of Allergy and Immunology, 158: 216-231.
    1. Bousquet, J., Schunemann, H.J., Samolinski, B.,… Potter, P.C.,… Bateman, E.D.,… Zar, H.J. et al Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs. Journal of Allergy and Clinical Immunology, 130: 1049-1062
    1. Boyles, T.H., Black, J.M., Meintjes, G. and Mendelson, M. 2012. Failure to eradicate isospora belli diarrhoea despite immune reconstitution in adults with HIV - a case series. PLoS One, 7(8): e42844.
    1. Boyles, T.H. and Maartens, G. 2012. Should tuberculin skin testing be a prerequisite to prolonged IPT for HIV-infected adults? International Journal of Tuberculosis and Lung Disease, 16(7): 857-859.
    1. Brehm, J.H., Koontz, D., Wallis, L., Shutt, K., Sanne, I., Wood, R., McIntyre, J., Stevens, W.S., Sluis-Cremer, N. and Mellors, J.W. 2012. Frequent emergence of N3481 in HIV-1 subtype C reverse transriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors. Clinical Infectious Diseases, 55(5): 737-745.
    1. Bryer, A. 2012. New antithrombotic drugs: a revolution in stroke management. Cardiovascular Journal of Africa, 23(2): 61-62.
    1. Bucci, M., Borra, R., Nagren, K., Parkka, J.P., Del Ry, S., Maggio, R., Tuunanen, H., Viljanen, T., Cabiati, M., Rigazio, S., Taittonen, M., Pagotto, U., Parkkola, R., Opie, L.H., Nuutila, P., Knuuti, J. and Lozzo, P. 2012. Trimetazidine reduces endogenous free fatty acid oxidation and improves mysocardial efficiency in obese humans. Cardiovascular Therapeutics, 30: 333-341.
    1. Burdzik, A., Jeebhay, M.F. and Todd, G. 2012. Occupational dermatitis in food processing workers with a special focus on the seafood processing industry - a review. Current Allergy & Clinical Immunology, 25(2): 88-93.
    1. Busse, W., Bleecker, E., Bateman, E.D., Lotvall, J., Forth, R., Davis, A.M., Jacques, L., Haumann, B. and Woodcock, A. 2012. Fluticasone furoate demonstrate efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial. Thorax, 67: 35-41.
    1. Cappelletti, A., Latib, A., Mazzavillani, M., Magni, V., Calori, G., Colombo, A., and Margonato, A. The coronary artery risk factors and prognostic localizaion study, C. 2012. Severity and prognostic localization of critical coronary artery stenoses: correlation with clinical control of major traditional risk factors. Coronary Artery Disease, 23: 455-459.
    1. Chantler, S., Dickie, K., Goedecke, J.H., Levitt, N.S., Lambert, E.V., Evans, J., Joffe, Y. and Micklesfield, L.K. 2012. Site-specific differences in bone mineral density in black and white premenopausal South African women. Osteoporosis International, 23: 533-542.
    1. Chapman, R.E., Shephard, E.G., Stutz, H., Douglass, N., Sambandamurthy, V., Garcia, I., Ryffel, B., Jacobs, W. and Williamson, A.-L. 2012. Priming with a recombinant pantothenate auxotroph of mycobacterium bovis BCG and boosting with MVA elicits HIV-1 gag specific CD8+ T Cells. PLoS One, 7(3): e32769.
    1. Chellan, P., Land, K.M., Shokar, A., Au, A., An, S.H., Clavel, C.M., Dyson, P.J., De Kock, C., Smith, P.J., Chibale, K. and Smith, G.S. 2012. Exploring the versatility of cycloplatinated thiosemicarbazones as antitumour and antiparasitic agents. Organometallics, 31: 5791-5799.
    1. Chigutsa, E., Meredith, S.A., Wiesner, J.L., Padayatchi, N., Harding, J., Moodley, P., Mac Kenzie, W.R., Weiner, M., McIlleron, H. and Kirkpatrick, C.M.J. 2012. Population pharmacokinetics and pharmacodynamics of ofloxacin in South African patients with multidrug-resistant tuberculosis. Antimicrobial Agents and Chemotherapy, 56(7): 3857-3863.
    1. Chin, A., Badri, M., Ntusi, N. and Okreglicki, A.M. 2012. The clinical, electrocardiographic and echocardiographic characteristics and long-term outcome of patients with tachycardia-induced cardiomyopathy. Cardiovascular Journal of Africa, 23(3): 136-142.
    1. Chockalingram, P., Crotti, L., Girardengo, G., Johnson, J.N., Harris, K.M., Van der Heijden, J., Hauer, R.N., Spazzolini, C., Rordorf, R., Rydberg, A., Clur, S.A.B., Fischer, M., Van den Heuvel, F., Kaab, S., Blom, N.A., Ackerman, M.J., Schwartz, P.J. and Wilde, A.A.M. 2012. Not all beta blockers are equal in the management of long QT syndrome types 1 and 2. Journal of the American College of Cardiology, 60: 2092-2099.
    2. Chukwujekwu, J.C., De Kock, C., Smith, P.J., van Heerden, F. and Van Staden, J. 2012. Antiplasmodial and antibacterial activity of compounds isolated from ormocarpum trichocarpum. Planta Medica, 78: 1857-1860.
    1. Cloete, T.T., Breytenbach, W.J., De Kock, C., Smith, P.J., Breytenbach, J.C.and N'Da, D.D. 2012. Synthesis, antimalarial activity and cytotoxicity of 10-aminoethylether derivatives of artemisinin. Bioorganic & Medicinal Chemistry, 20: 4701-4709.
    1. Conesa-Botella, A., Meintjes, G., Coussens, A.K., van Der Plas, H., Goliath, R., Schutz, C., Moreno-Reyes, R., Mehta, M., Martineau, A., Wilkinson, R.J., Colebunders, R. and Wilkinson, K. 2012. Corticosteriod therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome. Clinical Infectious Diseases, 55(7): 1004-1011.
    1. Cornell, M., Schomaker, M., Garone, D., Giddy, J., Hoffmann, C.J., Lessells, R., Maskew, M., Prozesky, H., Wood, R., Johnson, L.F., Egger, M., Boulle, A.M. and Myer, L. 2012. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study. Plos Medicine, 9(9): e1001304.
    1. Crotti, L., Marcou, C.A., Tester, D.J., Castelletti, S., Giudicessi, J.R., Torchio, M., Medeiros-Domingo, A., Simone, S., Will, M.L., Dagradi, F., Schwartz, P.J. and Ackerman, M.J. 2012. Spectrum and prevalence of mutations involving BrS1- though BrS12 - susceptibility genes in a cohort of unrelated patients referred for brugada syndrome genetic testing. Journal of the American College of Cardiology, 60(15): 1410-1418.
    1. Crotti, L., Hu, D., Barajas-Martinez, H., De Ferrari, G.M., Oliva, A., Insolia, R., Pollevick, G.D., Dagradi, F., Guerchicoff, A., Greco, F., Schwartz, P.J. and Viskin, S. 2012. Torsades de pointes following acute mycardial infaction: evidence for a deadly link with a common genetic variant. Heart Rhythm, 9: 1104-1112.
    1. Crotti, L., Spazzolini, C., Porretta, A.P., Dagradi, F., Taravelli, E., Petracci, B., Vicentini, A., Pedrazzini, M., La Rovere, M.T., Vanoli, E., Goosen, A., Heradien, M., George Jr, A.L., Brink, P. and Schwartz, P.J. 2012. Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk satisfaction in the long QT syndrome. Journal of the American College of Cardiology, 60(24): 2515-2524.
    1. Crotti, L. and Schwartz, P.J. 2012. When genetic screening for your patient with long QT syndrome comes back negative, don't always take a no for a no. Heart Rhythm, 9(12): 1983-1985.
    1. Damasceno, A., Mayosi, B.M., Sani, M., Ogah, O.S., Mondo, C., Ojji, D., Dzudie, A., Kauam, C., Suliman, A., Schreuder, N., Yonga, G., Ba, S.A., Maru, F., Alemayehu, B., Edwards, C., Davison, B.A., Cotter, G. and Sliwa, K. 2012. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Archives of Internal Medicine, 172(18): 1386-1394.
    1. Dandara, C., Scott, C., Urban, M., Fieggen, K., Arendse, R. and Beighton, P. 2012. Confirmation of the recurrent ACVRI 617G> a mutation in South Africans with fibrodysplasia ossificans progressiva. SAMJ South African Medical Journal, 102(7): 631-633.
    1. Davidavicius, G., Godino, C., Shannon, J., Takagi, K., Bertoldi, L., Mussardo, M., Chieffo, A., Arioli, F., Ielasi, A., Montorfano, M., Latib, A. and Colombo, A. 2012. Incedence of overall bleeding in patients treated with intra-aortic balloon pump during percutaneous coronary intervention. Journal of the American College of Cardiology, 5(3): 350-357.
    1. Davids, V., Blackhurst, D.M., Katz, A.A. and Harley, E.H. 2012. Origins and function of 3-ribosylurate in bovid erythrocytes. Veterinary Journal, 192: 326-332.
    1. Davies, M., Boulle, A.M., Technau, K., Eley, B.S., Moultrie, H., Rabie, H., Garone, D., Giddy, J., Wood, R., Egger, M. and Keiser, O. 2012. The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure. Tropical Medicine & International Health, 17(11): 1386-1390.
    1. Decloedt, E.H., Maartens, G., Smith, P.J., Merry, C., Bango, F. and McIlleron, H. 2012. The safety, effectiveness and concentrations of adjusted lopinavir/ritonavir in HIV-infected adults on rifampicin-based antitubercular therapy. PLoS One, 7(3): e32173.
    1. Deetlefs, E., Epstein, D., Watermeyer, G., Seggie, R.M. and Thomson, S.R. 2012. Tuberculosis in an inflammatory bowel disease cohort from South Africa. SAMJ South African Medical Journal, 102(10): 802-804.
    1. Dheda, K. and Migliori, G.B. 2012. The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue? Lancet, 379: 773-775.
    1. Diacon, A., Dawson, R., von Groote-Bidlingmaier, F., Symons, G.J., Venter, A., Donald, P.R., van Niekerk, C., Everitt, D., Winter, H., Becker, P., Mendel, C.M. and Spigelman, M.K. 2012. 14-day bacterial activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial. Lancet, 380: 986-993.
    1. Diacon, A., Dawson, R., du Bois, J., Narunsky, K., Venter, A., Donald, P.R., van Niekerk, C., Erondu, N., Ginsberg, A.M., Becker, P. and Spigelman, M.K. 2012. Phase II dose-ranging trial of the early bactericidal activity of PA-824. Antimicrobial Agents and Chemotherapy, 56(6): 3027-3031.
    1. Diacon, A., Maritz, S.J., Venter, A., Van Helden, P., Dawson, R. and Donald, P.R. 2012. Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents. Clinical Microbiology and Infection, 18: 711-717.
    1. Dimatelis, J., Pillay, N., Mutyaba, A., Russell, V.A., Daniels, W.M.U. and Stein, D.J. 2012. Early maternal separation leads to down-regulation of cytokine gene expression. Metabolic Brain Disease, 27: 393-397.
    1. Dlamini, S.K. and Mendelson, M. 2012. Atypical pneumonia in adults in Southern Africa. South African Family Practice, 54(4): 286-297.
    1. Echouffo-Tcheugui, J.B., Dzudie, A., Epacka, M.E., Choukem, S.P., Doualla, M.S., Luma, H. and Kengne, A.P. 2012. Prevalence and determinants of undiagnosed diabetes in an urban sub-Saharan African population. Primary Care Diabetes, 6: 229-234.
    1. Echouffo-Tcheugui, J.B. and Kengne, A.P. 2012. Risk models to predict chronic kidney disease and its progression: a systematic review. PLoS One, 9(11): e1001344.
    1. Echouffo-Tcheugui, J.B., Mayige, M., Ogbera, A.O., Sobngwi, E. and Kengne, A.P. 2012. Screening for hyperglycemia in the developing world: rationale, challenges and opportunities. Diabetes Research and Clinical Practice, 98: 199-208.
    1. Ehrlich, R.I., Woolf, D.C. and Kibel, D.A. 2012. Disulfiram reaction in an artist exposed to solvents. Occupational Medicine-Oxford, 62: 64-66.
    1. Epstein, D., Mistry, K., Whitelaw, A.C., Watermeyer, G. and Pettengell, K.E. 2012. The effect of physiological concentration of bile acids on the in vitro growth of mycobacterium tuberculosis. SAMJ South African Medical Journal, 102(6): 522-524.
    1. Esmail, H., Barry 3rd, C.E. and Wilkinson, R.J. 2012. Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies. Drug Discovery Today, 17(9/10): 514-521.
    1. EstilL, J., Aubriere, C., Egger, M., Johnson, L.F., Wood, R., Garone, D., Gsponer, T., Wandeler, G., Boulle, A.M., Davies, M., Hallett, T.B. and Keiser, O. 2012. Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in southern Africa: a mathematical modelling analysis. Aids, 26: 1403-1413.
  • F - J

    1. Fairall, L., Bachmann, M.O., Lombard, C., Timmerman, V., Uebel, K., Zwarenstein, M., Boulle, A.M., Georgeu, D., Colvin, C., Lewin, S.A., Faris, G.F., Cornick, R.V., Draper, B., Tshabalala, M., Kotze, E., Van Vuuren, C., Steyn, D., Chapman, R. and Bateman, E.D. 2012. Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa: a pragmatic, parallel, cluster-randomised trial. Lancet, 380: 889-898.
    1. Fatti, G., Meintjies, G., Shea, J., Eley, B.S. and Grimwood, A. 2012. Improved survival and antiretroviral treatment outcomes in adults receiving community-based adherence support: 5-year results from a multicentre cohort study in South Africa. Jaids-Journal of Acquired Immune Deficiency Syndromes, 61(4): e50-e58.
    1. Fox, M.P., Van Custem, G., Giddy, J., Maskew, M., Keiser, O., Prozesky, H., Wood, R., Hernan, M., Sterne, J.A.C., Egger, M. and Boulle, A.M. 2012. Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line art in South Africa. Jaids-Journal of Acquired Immune Deficiency Syndromes, 60(4): 428-437.
    1. Freercks, R., Swanepoel, C.R., Carrara, H., Moosa, S.E., Lachman, A. and Rayner, B.L. 2012. Vascular calcification in South African dialysis patients: ethnic variation, prevalence, detection and haemodynamic correlates. Nephrology, 17: 607-615.
    1. Gabriels, G.A., Lambert, M.I. and Smith, P.J. 2012. Information on nutritional supplement labels: time for legislation. South African Journal of Clinical Nutrition, 25(1): 22-26.
    1. Georgeu, D., Colvin, C.J., Lewin, S., Fairall, L., Bachmann, M.O., Uebel, K., Zwarenstein, M., Draper, B. and Bateman, E.D. 2012. Implementing nurse-initiated and managed antiretroviral treament (NIMART) in South Africa: a qualitative process evaluation of the stretch trial. Implementation Science, 7:66.
    1. Gideon, H., Wilkinson, K., Rustad, T.G., Oni, T., Guio, H., Sherman, D.R., Vordermeier, H., Robertson, B.D., Young, D.B. and Wilkinson, R.J. 2012. Bioinformatic and emperical analysis of novel hypoxia-inducible targets of the human antituberculosis t cell response. Journal of Immunology, 189: 5867-5876.
    1. Glans, L., Ehnbom, A., De Kock, C., Martinez, A., Estranda, J., Smith, P.J., Haukka, M., Sanchez-Delgado, R.A. and Nordlander, E. 2012. Ruthenium(II) arene complexes with chelating chloroquine analogue ligands: synthesis, characterization and in vitro antimalarial activity. Dalton Transactions, 41: 2764-2773.
    1. Glans, L., Hu, W., Jost, C., De Kock, C., Smith, P.J., Haukka, M., Bruhn, H., Schatzschneider, U. and Nordlander, E. 2012. Synthesis and biological activity of cymantrene and cyrhetrene 4 -aminoquiline conjugates against malaria, leishmaniasis, and trypanosomiasis. Dalton Transactions, 41: 6443-6450.
    1. Gnecchi, M. and Schwartz, P.J. 2012. The unstoppable attraction for induced pluripotent stem cells. Journal of the American College of Cardiology, 60(11): 1001-1004.
    1. Graves, R.R. and Burch, V. 2012. Socks: launching education innovations on a firm footing. Medical Education, 46: 1099-1136.
    1. Graziose, R., Rojas-Silva, P., Rathinasabapathy, T., De Kock, C., Grace, M.H., Poulev, A., Lila, M.A., Smith, P.J. and Raskin, I. 2012. Antiparasitic compounds from Cornus florida L. with activities against plasmodium falciparum and Leishmania tarentolae. Journal of Ethnopharmacology, 142: 456-461.
    1. Smith, D., Bryer, A., Watson, L. and Greenberg, J. 2012. Inherited polyglutamine spinocerebellar ataxias in South Africa. SAMJ South African Medical Journal, 102(8): 683-686.
    1. Gupta, A., Wood, R., Kaplan, R., Bekker, L. and Lawn, S.D. 2012. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS One, 7(3): e34156.
    1. Hanlyn, E., Hickling, S., Porter, K., Frater, J., Phillips, R., Robinson, M., Mackie, N.E., Kaye, S., McClure, M., Filder, S., Wood, R., Pitt, J.A., Orrell, C., Cilliers, C., Croxford, R., Middelkoop, K., Bekker, L., Heiberg, C., Aploon, J., Killa, N.J., Fielder, E. and Buhler, T.C. 2012. Increased levels of CD4 T-cell activation inindividuals with CXCR4 using viruses in primary HIV-1 infection. AIDS, 26: 887896.
    1. Harries, A.D., Lawn, S.D., Getahun, H., Zachariah, R. and Havlir, D. 2012. HIV and tuberculosis - science and implementation to turn the tide and reduce deaths. Journal of the International AIDS Society, 15: 17396.
    1. Hartman, N., Kathard, H., Perez, G., Reid, S., Irlam, J.H., Gunston, G.D., Janse van Rensburg, V.C., Burch, V.C., Duncan, E.M., Hellenberg, D.A., Van Rooyen, I.W., Smouse, M.R., Sikakana, C.N.T., Badenhorst, E.S. and Ige, B. 2012. Health sciences undergraduate education at University of Cape Town: a story of transformation. SAMJ South African Medical Journal, 102(6): 477-480.
    1. Heckmann, J.M., Hansen, P., van Toorn, R., Lubbe, E., van Rensburg, E.J. and Wilmshurst, J. 2012. The characteristics of juvenile myasthenia gravis among South Africans. SAMJ South African Medical Journal, 102(6): 532-536.
    1. Helgadottir, A., Gretarsdottir, S., Thorleifsson, G., … Mayosi, B.M. et al. 2012. Apoliptrotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. Journal of the American College of Cardiology, 60(8): 722-729.
    1. Hendrik, S.H., Sudano, I., Theus, G., Noll, G. and Burnier, M. 2012. Target blood pressure attainment with antihypertensive therapy in Swiss primary care. Blood Pressure, 21(4): 211-219.
    1. Herrmann, C., Salas, P.F., Cawthray, J.F., De Kock, C., O Patrick, B., Smith, P.J., Adam, M.J. and Orvig, C. 2012. 1,1'-Disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarials. Organometallics, 31: 5736-5747.
    1. Herrmann, C., Salas, P.F., O Patrick, B., De Kock, C., Smith, P.J., Adam, M.J. and Orvig, C. 2012. 1,2-Disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarial agents. Dalton Transactions, 41: 6431-6442.
    1. Herrmann, C., Salas, P.F., O Patrick, B., De Kock, C., Smith, P.J., Adam, M.J. and Orvig, C. 2012. Modular synthesis of 1,2- and 1,1'-disubstituted ferrocenyl carbohydrate chloroquine and mefloquine conjugates as potential antimalarial agents. Organometallics, 31: 5748-5759.
    1. Holgate, S.L., Rabie, H., Smith, P. and Cotton, M. 2012. Trough lopinavir concentrations in preterm HIV-infected infants. Pediatric Infectious Disease Journal, 31(6): 602-604.
    1. Howard, A., Gasana, M., Getahun, H., Harries, A.D., Lawn, S.D., Miller, B., Nelson, L., Sitienei, J. and Coggin, W.L. 2012. PEPFAR support for the scaling up of collaborative TB/HIV activities. Jaids-Journal of Acquired Immune Deficiency Syndromes, 60(3): S136-S144.
    1. Hu, D., Barajas-Martinez, H., Medeiros-Domingo, A., Crotti, L., Veltmann, C., Schimpf, R., Urrutia, J., Alday, A., Casis, O., Pfeiffer, R., Burashnikov, E., Caceres, G., Tester, D.J., Wolpert, C., Borggrefe, M., Schwartz, P.J., Ackerman, M.J. and Antzelevitch, C. 2012. A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Nav1.5 and Kv4.3 channel currents. Heart Rhythm, 9(5): 760-769.
    1. Huisamen, B., Dietrich, D., Bezuidenhout, N., Lopes, J., Flepisi, B., Blackhurst, D.M. and Lochner, A. 2012. Early cardiovascular changes occuring in diet-induced, obese insulin-resistant rats. Molecular and Cellular Biochemistry, 368: 37-45.
    1. Isaacs, T. 2012. Skin hypersensitivity reactions to preservatives. Current Allergy & Clinical Immunology, 25(1): 41-45.
    1. Ishikawa, T., Sato, A., Marcou, C.A., Tester, D.J., Ackerman, M.J., Crotti, L., Schwartz, P.J., On, Y.K., Park, J.E., Nakamura, K., Hiraoka, M., Nakazawa, K., Sakurada, H., Arimura, T., Makita, N. and Kimura, A. 2012. A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. Circulation-Arrhythmia and Electrophysiology, 5: 1098 -1107.
    1. Jackson, A., Nussbaum, J.C., Phulusa, J., Namarika, D., Chikasema, M., Kanyemba, C., Jarvis, J.N., Jaffar, S., Hosseinipour, M., van der Horst, C. and Harrison, T. 2012. A phase II randomized controlled trial adding oral flucytosine to high - dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis. Aids, 26: 1363-1370.
    1. James, R.W., Frias, M.A. and Lecour, S. 2012. Lipid-induced modulation of protective signalling pathways in cardiovascular disease: the role of high density lipoproteins. Current Signal Transduction Therapy, 7(2): 96-103.
    1. Jarvis, J.N., Meintjes, G., Rebe, K., Williams, G.M., Bicanic, T., Williams, A., Schutz, C., Bekker, L., Wood, R. and Harrison, T. 2012. Adjunctive interferon- immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial. Aids, 26: 1105-1113.
    1. Jones, E., Owen, P. and Rayner, B.L. 2012. The association of the R563Q genotype of the ENaC with phenotypic variation in Southern Africa. American Journal of Hypertension, 25(12): 1286-1291.
    1. Jones, P.W., Singh, D., Bateman, E.D., Agusti, A., Lamarca, R., de Miquel, G., Segarra, R., Caracta, C. and Gil, E.G. 2012. Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study. European Respiratory Journal, 40(4): 830-836.
  • K - O

    1. Karthikeyan, G., Zuhlke, L., Engel, M.E., Rangarajan, S., Yusuf, S., Teo, K. and Mayosi, B.M. 2012. Rationale and design of a global rheumatic heart disease registry: the remedy study. American Heart Journal, 163: 535-540.
    1. Kaze, F.F., Ashuntantang, G., Kengne, A.P., Hassan, A., Halle, M.P. and Muna, W. 2012. Acute hemodialysis complications in end-stage renal disease patients: the burden and implications for the under-resourced Sub-Saharan African health systems. Hemodialysis International, 16: 526-531.
    1. Kengne, A.P., Ntyintyane, L. and Mayosi, B.M. 2012. A systematic overview of prospective cohort studies of cardiovascular disease in sub-Saharan Africa. Cardiovascular Journal of Africa, 23(2): 103-112.
    1. Kengne, A.P., Czernichow, S., Hamer, M., Batty, D. and Stamatakis, E. 2012. Anaemia, haemoglobin level and cause - specific mortality in people with and without diabetes. PLoS One, 7(8): e41875.
    1. Kengne, A.P., Batty, D., Hamer, M., Stamatakis, E. and Czernichow, S. 2012. Association of C-reactive protein with cardiovascular disease mortality according to diabetes status. Diabetes Care, 35: 396-403.
    1. Kengne, A.P., Czernichow, S., Stamatakis, E., Hamer, M. and Batty, D. 2012. Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: pooling of three British health surveys. Journal of Hepatology, 57: 1083-1089.
    1. Kengne, A.P., Limen, S.N., Sobngwi, E., Djouogo, C.F.T. and Nouedoui, C. 2012. Metabolic syndrome in type 2 diabetes: comparative prevalence according to two sets of diagnostic criteria in sub-Saharan Africans. Diabetology & Metabolic Syndrome, 22(4): 1-8.
    1. Kenyon, C., Mfolozi, S., Croxford, R., Colebunders, R. and Cohen, K. 2012. Severe efavirenz-induced vacuolar axonopathy complicated by fatal aspiration pneumonia. British Journal of Clinical Pharmacology, 74(6): 1070-1072.
    1. Kenyon, C., Schreuder, N., Ntsekhe, M. and Meintjes, G. 2012. Heart failure and cardiogenic shock associated with the TB-immune reconstitution inflammatory syndrome. Cardiovascular Journal of Africa, 23(3): e14-e17.
    1. Kenyon, C., Fatti, G., Schreuder, N., Bonorchis, K. and Meintjes, G. 2012. The value of blood culture audits at peripheral hospitals. SAMJ South African Medical Journal, 102(4): 224-225.
    1. Kenyon, C. and Colebunders, R. 2012. What is the optimal first line antiretroviral therapy in resouce-limited settings? Plos Medicine, 9(8): e1001291.
    1. Kerkhoff, A., Kranzer, K., Samandari, T., Nakiyingi-Miiro, J., Whalen, C.C., Harries, A.D. and Lawn, S.D. 2012. System review of TST responses in people living with HIV in under-resourced settings: implications for isoniazid preventive therapy. PLoS One, 7(11): e49928.
    1. Kerstjens, H.A.M., Engel, M., Dahl, R., Paggiaro, P., Beck, E., Vandewalker, M., Sigmund, R., Seibold, W., Moroni-Zentgraf, P. and Bateman, E.D. 2012. Tiotropium in asthma poorly controlled with standard combination therapy. New England Journal of Medicine, 367: 1198-1207.
    1. Kew, M.C. 2012. Hepatitis B virus / human immunodeficiency virus co-infection and Its hepatocarcinogenic potential in Sub-Saharan black africans. Hepatitis Monthly, 12: e7876.
    1. Khumalo, N. and Gumedze, F.N. 2012. The adapted classification of male pattern hair loss improves reliability. Dermatology, 225(2):110-114.
    1. Khumalo, N. and Gumedze, F.N. 2012. Traction: risk factor or coincidence in central centrifugal cicatricial alopecia? British Journal of Dermatology, 167(5): 1191-1193.
    1. Kimmel, A.D., Daniels, N., Betancourt, T., Wood, R. and Prosser, L.A. 2012. Decision maker priorities for providing antiretroviral therapy in HIV-infected South Africans: a qualitative assessment. Aids Care, 24(6): 778-792.
    1. Kranzer, K., Lawn, S.D., Meyer-Rath, G., Vassall, A., Raditlhalo, E., Govindasamy, D., Van Schaik, N., Wood, R. and Bekker, L. 2012. Feasibility, yield, and cost of active tuberculosis case finding linked to a mobile HIV science in Cape Town, South Africa: a cross-sectional study. PLoS One, 9(8): e1001281.
    1. Kranzer, K., Govindasamy, D., Van Schaik, N., Thebus, L., Davies, N., Zimmerman, M.A., Jeneker, S., Lawn, S.D., Wood, R. and Bekker, L. 2012. Incentivized recruitment of a population sample to a mobile HIV testing service increases the yield of newly diagnosed cases, including those in need of antiretroviral therapy. HIV Medicine, 13: 132-137.
    1. Lamont, K., Blackhurst, D.M., Albertyn, Z., Marais, A.D. and Lecour, S. 2012. Lowering the alcohol content of red wine does not alter its cardioprotective properties. SAMJ South African Medical Journal, 102(6): 565-567.
    1. Langat, M.K., Crouch, N., Pohjala, L., Tammela, P., Smith, P.J. and Mulholland, D.A. 2012. Ent-kauren-19-oic acid derivatives from the stem bark of croton pseudopulchellus pax. Phytochemistry Letters, 5: 414-418.
    1. Langhorne, P., De Villiers, L. and Pandian, J.D. 2012. Applicability of stroke-unit care to low-income and middle income countries. Lancet Neurology, 11: 341-348.
    1. Latib, A., Colombo, A., Castriota, F., Micari, A., Cremonesi, A., De Felice, F., Marchese, A., Tespili, M., Presbitero, P., Sgueglia, G.A., Buffoli, F., Tamburino, C., Varbella, F. and Menozzi, A. 2012. A randomized multicenter study comparing a paclitaxel-eluting stent in small coronary vessels. Journal of the American College of Cardiology, 60(24): 2473-2480.
    1. Latib, A., Montorfano, M., Figini, F., Maisano, F., Chieffo, A., Benussi, S., Bellanca, R., Gerli, C., Spagnolo, P., Alfieri, O. and Colombo, A. 2012. Percutaneous valve replacement in a young adult for radiation-induced aortic stenosis. Journal of Cardiovascular Medicine, 13: 397-398.
    1. Latib, A., Maisano, F., Bertoldi, L., Giacomini, A., Shannon, J., Cioni, M., Ielasi, A., Figini, F., Tagaki, K., Franco, A., Covello, R.D., Grimaldi, A., Spagnolo, P., Buchannan, G.L., Carlino, M., Chieffo, A., Montorfano, M., Alfieri, O. and Colombo, A. 2012. Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control study. American Heart Journal, 164: 910-917.
    1. Latka, M.H., Fielding, K.L., Gray, G., Bekker, L., Nchabeleng, M., Mlisana, K., Nielson, T., Roux, S.M., Mkhize, B., Mathebula, M., Naicker, N., de Bruyn, G., Kublin, J.G. and Churchyard, G.J. 2012. Pregnancy incidence and correlates during the HVTN 503 phambili HIV vaccine trial conducted among South African Women. PLoS One, 7(4): e31387(1).
    1. Lawn, S.D. 2012. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infectious Diseases, 12:103.
    1. Lawn, S.D. and Zumla, A. 2012. Diagnosis of extrapulmonary tuberculosis using the Xpert MTB/RIF assay. Expert Review of Anti-Infective Therapy, 10(6): 631-635.
    1. Lawn, S.D., Harries, A.D., Meintjes, G., Getahun, H., Havlir, D. and Wood, R. 2012. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa. AIDS, 26(17): 2121-2133.
    1. Lawn, S.D., Kerkhoff, A., Pahlana, P., Vogt, M.C. and Wood, R. 2012. Diagnostic yield of tuberculosis using sputum induction in HIV-positive patients before antiretroviral therapy. International Journal of Tuberculosis and Lung Disease, 16(10): 1354-1357.
    1. Lawn, S.D., Kerkhoff, A., Vogt, M.C. and Wood, R. 2012. Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis. AIDS, 26: 1635-1643.
    1. Lawn, S.D., Kerkhoff, A., Vogt, M.C. and Wood, R. 2012. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infectious Diseases, 12: 201-209.
    1. Lawn, S.D., Kerkhoff, A., Vogt, M.C. and Wood, R. 2012. High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the xpert MTB/RIF assay. Jaids-Journal of Acquired Immune Deficiency Syndromes, 60: 289-294.
    1. Lawn, S.D., Kerkhoff, A., Vogt, M.C., Ghegrekristos, Y., Whitelaw, A.C. and Wood, R. 2012. Characteristics and early outcomes of patients with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy. Clinical Infectious Diseases, 54(8): 1071-1079.
    1. Lehloenya, R.J., Wallance, J., Todd, G. and Dheda, K. 2012. Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients. International Journal of Tuberculosis and Lung Disease, 16(9): 1260-1264.
    1. Lekoubou, A., Kengne, A.P., Fezeu, L. and Mbanya, J.C. 2012. Determinants of active convulsive epilepsy in rural Cameroon: a population based case-control study. Neurological Research, 34(2): 159-162.
    1. Levin, D.A., Watermeyer, G., Deetlefs, E., Metz, D.C. and Thomson, S.R. 2012. The efficacy of endoscopic therapy in bleeding peptic ulcer patients. SAMJ South African Medical Journal, 102(5): 290-293.
    1. Levison, J.H., Orrell, C., Gallien, S., Kuritzkes, D.R., Fu, N., Losina, E., Freedberg, K.A. and Wood, R. 2012. Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa. PLoS One, 7(3): e32144.
    1. Lombard, M.C., N'Da, D.D., Breytenbach, J.C., Kolesnikova, N.I., Tran Van Ba, C., Wein, S., Norman, J.J., Denti, P., Vial, H. and Wiesner, L. 2012. Antimalarial and anticancer activities of artemisinin-quinoline hybrid-dimers and pharmacokinetic properties in mice. European Journal of Pharmaceutical Sciences, 47: 834-841.
    1. Lorenzana, S.B., Hughes, M., Grinsztejn, B., Collier, A., Luz, P.M., Freedberg, K.A., Wood, R., Levison, J.H., Mugyenyi, P., Salata, R., Wallis, L., Weinstein, M., Schooley, R.T. and Walensky, R.P. 2012. Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial. Aids, 26: 1083-1093.
    1. Lotvall, J., Bateman, E.D., Bleecker, E., Busse, W., Woodcock, A., Follows, R., Lim, J., Stone, S., Jacques, L. and Haumann, B. 2012. 24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids. European Respiratory Journal, 40(3): 570-579.
    1. Lowe, D., Redford, P.S., Wilkinson, R.J., O'Garra, A. and Martineau, A. 2012. Neutrophils in tuberculosis: friend or foe? Trends in Immunology, 33(1): 14-25.
    1. Loyse, A., Wilson, D., Meintjes, G., Jarvis, J.N., Bicanic, T., Bishop, L., Rebe, K.B., Williams, A., Jaffar, S., Bekker, L., Wood, R. and Harrison, T. 2012. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis. Clinical Infectious Diseases, 54(1): 121-128.
    1. Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S., Matzopoulos, R., Mayosi, B.M., Mensah, G. and Sliwa, K. 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet, 380: 2095-2128.
    1. Maarman, G., Marais, E., Lochner, A. and du Toit, E.F. 2012. Effect of chronic CPT-1 inhibition on myocardial ischemia-reperfusion injury (I/R) in a model of diet-induced obesity. Cardiovascular Drugs and Therapy, 26: 205-216.
    1. Macharia, M., Hassan, M.S., Blackhurst, D.M., Erasmus, R.T. and Matsha, T.E. 2012. The growing importance of PON1 in cardiovascular health: a review. Journal of Cardiovascular Medicine, 13: 443-453.
    1. Mahler, D.A., D'Urzo, A., Bateman, E.D., Ozkan, S.A., White, T., Peckitt, C., Lassen, C. and Kramer, B. 2012. Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison. Thorax, 67: 781-788.
    1. Marais, D., Blom, D., Petrides, F., Goueffic, Y. and Lambert, G. 2012. Proprotein convertase subtilisin/kexin type 9 inhibition. Current Opinion in Lipidology, 23: 511-517.
    1. Mark, D., Middelkoop, K., Black, S., Roux, S.M., Fleur, L., Wood, R. and Bekker, L. 2012. Low acceptability of medical male cicumcision as an HIV/AIDS prevention intervention within a South African community that practises traditional circumcision. SAMJ South African Medical Journal, 102(6): 571-573.
    1. Mash, B., Fairall, L., Adejayan, O., Ikpefan, O., Kumari, J., Mathee, S., Okun, R. and Yogolelo, W. 2012. A morbidity survey of South African primary care. PLoS One, 7(3): e32358.
    1. Mash, B., Levitt, N., Steyn, K., Zwarenstein, M. and Rollnick, S. 2012. Effectiveness of a group diabetes education programme in underserved communities in South Africa: pragmatic cluster randomized control trial. BMC Family Practice, 13:126.
    1. Maspero, J.F., Lee, B.W., Katelaris, C.H., Potter, P.C., Cingi, C., Lopatin, A., Saffer, M., Nadeau, G. and Walters, R.D. 2012. Quality of life and control of allergic rhinitis in patients from regions beyond Western Europe and the United States. Clinical and Experimental Allergy, 42: 1684-1696.
    1. Matsha, T.E., Masconi, K., Yako, Y.Y., Hassan, M.S., Macharia, M., Erasmus, T. and Kengne, A.P. 2012. Polymorphisms in the non-muscle myosin heavy chain gene (MYH9) are associated with lower glomerular filtration rate in mixed ancestry diabetic subjects from South Africa. PLoS One, 7(12): e52529.
    1. Matthews, K., Ntsekhe, M., Syed, F., Scriba, T.J., Russell, J.B.W., Tibazarwa, K., Deffur, A., Hanekom, W.A., Mayosi, B.M., Wilkinson, R.J. and Wilkinson, K. 2012. HIV-1 infection alters CD4+ memory T-cell phenotype at the site of disease in extrapulmonary tuberculosis. European Journal of Immunology, 42: 147-157.
    1. Mayer, K.H., Bekker, L., Stall, R., Grulich, A.E., Colfax, G. and Lama, J.R. 2012. Comprehensive clinical care for men who have sex with men: an integrated approach. Lancet, 380: 378-387.
    1. Mayosi, B.M. and Forrester, T.E. 2012. Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda' by AG Shaper and KW Jones. International Journal of Epidemiology, 41: 1233-1235.
    1. Mayosi, B.M., Lawn, J.E.L., van Niekerk, A., Bradshaw, D., Karim, S.S.A. and Coovadia, H. 2012. Health in South Africa: changes and challenges since 2009. Lancet, 380: 2029-2043.
    1. Mbeunkui, F., Grace, M.H., Lategan, C.A., Smith, P.J., Raskin, I. and Lila, M.A. 2012. In vitro antiplasmodial activity of indole alkaloids from the stem bark of Geissospermum vellosii. Journal of Ethnopharmacology, 139: 471-477.
    1. McIlleron, H., Rustomjee, r., Vahedi, M., Mthiyane, T., Denti, P., Connolly, C., Rida, W., Pym, A., Smith, P.J. and Onyebujoh, P.C. 2012. Reduced antituberculosis drug concerntrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines. Antimicrobial Agents and Chemotherapy, 56(6): 3232-3238.
    1. McNerney, R., Maeurer, M., Abubakar, I., Marais, B., McHugh, T., Ford, N., Weyer, K., Lawn, S.D., Grobusch, M.P., Memish, Z., B Squire, B., Pantaleo, G., Chakaya, J., Casenghi, M., Migliori, G.B., Mwaba, P., Zijenah, L., Hoelscher, M., Cox, H., Swaminathan, S., Kim, P., Schito, M., Harari, A., Bates, M., Schwank, S., O'Grady, J., Pletschette, M., Ditui, L., Atun, R. and Zumla, A. 2012. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. Journal of Infectious Diseases, 205: S147-158.
    1. Meintjes, G., Skolimowska, K., Wilkinson, K., Matthews, K., Tadokera, R., Conesa-Botella, A., Seldon, R.R., Rangaka, M.X., Rebe, K.B., Pepper, D.J., Morroni, C., Colebunders, R., Maartens, G. and Wilkinson, R.J. 2012. Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome. American Journal of Respiratory and Critical Care Medicine, 186(4): 369-377.
    1. Meissner, P.N., Corrigall, A.V. and Hift, R. 2012. Fifty years of porphyria at the Unvirsity of Cape Town. SAMJ South African Medical Journal, 102(6): 422-426.
    1. Mendelson, M., Barday, Z., Eastman, R.W., Le Feuvre, D.E.J., Candy, S., Wu, H. and Swanepoel, C.R. 2012. Rapidly progressive post-transplant lymphoproliferative disease following withdrawal of sirolimus. SAMJ South African Medical Journal, 102(12): 924-928.
    1. Meredith, S.A., Smith, P.J., Norman, J.J. and Wiesner, L. 2012. An LC-MS/MS method for the determination of ofloxacin in 20 1 human plasma. Journal of Pharmaceutical and Biomedical Analysis, 58: 177-181.
    1. Metha, U., Clerk, C., Allen, E., Yore, M., Sevene, E., Singlovic, J., Petzold, M., Mangiaterra, V., Elefant, E., Sullivan, F.M., Holmes, L.B. and Gomes, M. 2012. Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings. BMC Pregnancy and Childbirth, 12:89.
    1. Middelkoop, K., Bekker, L., Shashkina, E., Kreiswirth, B. and Wood, R. 2012. Retreatment tuberculosis in a South African community: the role of re-intection, HIV and antiretroviral treatment. International Journal of Tuberculosis and Lung Disease, 16(11): 1510-1516.
    1. Migliori, G.B., Zellweger, J.P., Abubakar, I., Caminero, J.A., de Vries, G., D'Ambrosio, L., Centis, R., Sotgiu, G., Menegale, O., Kliiman, K., Aksamit, T., Cirillo, D.M., Danilovits, M., Dara, M., Dheda, K., Dinh-Xuan, A.T., Kluge, H., Lange, C., Leimane, V., Loddenkemper, R., Nicod, L.P., Raviglione, M.C., Spanevello, A., Thomsen, V.O., Villar, M., Wanlin, M., Wedzicha, J.A., Zumla, A., Blasi, F., Huitric, E., Sandgren, A. and Manissero, D. 2012. European union standards for tuberculosis care. European Respiratory Journal, 39(4): 807-819.
    1. Mocumbi, A.O. and Sliwa, K. 2012. Women's cardiovascular health in Africa. Heart, 98: 450-455.
    1. Montgomery, E.T., van der Straten, A., Cheng, H., Wegner, L., Masenga, G., von Mollendorf, C., Bekker, L., Ganesh, S., Young, K., Romano, J., Nel, A. and Woodsong, C. 2012. Vaginal ring adherence in Sub-Saharan Africa: expulsion, removal, and perfect use. Aids and Behavior, 16: 1787-1798.
    1. Moons, K.G.M., Kengne, A.P., Grobbee, D.E., Royston, P., Vergouwen, Y., Altman, D.G. and Woodward, M. 2012. Risk prediction models: II. external validation, model updating, and impact assessment. Heart, 98: 691-698.
    1. Moons, K.G.M., Kengne, A.P., Woodward, M., Royston, P., Vergouwen, Y., Altman, D.G. and Grobbee, D.E. 2012. Risk prediction models: I. development, internal validation, and assessing the incremental value of a new (bio)marker. Heart, 98: 683-690.
    1. Morrow, C.D., Munro, A., Wilke, M., Stark, R. and Wood, R. 2012. Remote sensing of HIV care programme using centrally collected laboratory results: can we monitor ART programmes effectiveness. SAMJ South African Medical Journal, 102(6): 501-505.
    1. Mosendane, T., Kew, M.C., Osih, R. and Mahomed, A. 2012. Nurses at risk for occupationally acquired blood-borne virus infection at a South African academic hospital. SAMJ South African Medical Journal, 102(3): 153-156.
    1. Mufhandu, H.T., Gray, E.S., Madiga, M.C., Tumba, N.L., Alexandre, K.B., Khoza, T., Wibmer, C.K., Moore, P.L., Morris, L. and Khati, M. 2012. UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C. Journal of Virology, 86(9): 4989-4999.
    1. Muller, E., Barday, Z., Mendelson, M. and Kahn, D. 2012. Renal transplantation between HIV-positive donors and recipients justified. SAMJ South African Medical Journal, 102(6): 497-498.
    1. Murdoch-Eaton, D., Manning, D., Kwizera, E., Burch, V., Pell, G. and Whittle, S. 2012. Profiling undergraduates' generic learning skills on entry to medical school; an international study. Medical Teacher, 34: 1033-1046.
    1. Murphy, R.A., Sunpath, H., Castilla, C., Ebrahim, S., Court, R.G., Nguyen, H., Kuritzkes, D.R., Marconi, V.C. and Nachega, J.B. 2012. Second-line antiretroviral therapy: long term outcomes in South Africa. Jaids-Journal of Acquired Immune Deficiency Syndromes, 61(2): 158-163.
    1. Murray, C.J.L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J.A., Abdalla, S., Matzopoulos, R. and Mayosi, B.M. 2012. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380(December 15): 2197-2223.
    1. Myer, L., Zulliger, R., Bekker, L. and Abrams, E. 2012. Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study. BMC Pregnancy and Childbirth, 12:94.
    1. Myers, L., Zulliger, R., Black, S., Pienaar, D. and Bekker, L. 2012. Pilot programme for the rapid initiation of antiretroviral therapy in pregnancy in Cape Town, South Africa. Aids Care, 24(8): 986-992.
    1. Nachega, J.B., Uthman, O.A., Yo, Y.-S., Lo, M., Anude, C., Kayembe, P., Wabwire-Mangen, F., Gomo, E., Sow, P.S., Obike, U., Kusiaku, T., Mills, E., Mayosi, B.M. and Ijsselmuiden, C. 2012. Current status and future prospects of epidemiology and public health training and research in the WHO African region. International journal of epidemiology, 41: 1829-1846.
    1. Nachega, J.B., Morroni, C., Chaisson, R., Goliath, R., Efron, A., Ram, M. and Maartens, G. 2012. Impact of Immune reconstitution inflammatory syndrome on antiretroviral therapy adherence. Patient Preference and Adherence, 6: 887-891.
    1. Nglazi, M., Kaplan, R., Caldwell, J., Peton, N., Lawn, S.D., Wood, R. and Bekker, L. 2012. Antiretroviral treatment uptake in patients with HIV-associated TN attending co-located TB and ART services. SAMJ South African Medical Journal, 102(12): 936-939.
    1. Nglazi, M., Kranzer, K., Holele, P., Kaplan, R., Mark, D., Jaspan, H.B., Lawn, S.D., Wood, R. and Bekker, L. 2012. Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa. BMC Infectious Diseases, 12:21.
    1. Nglazi, M., Van Schaik, N., Kranzer, K., Lawn, S.D., Wood, R. and Bekker, L. 2012. An incentivized HIV counseling and testing program targeting hard-to-reach unemployed men in Cape Town, South Africa. Jaids-Journal of Acquired Immune Deficiency Syndromes, 59(3): e28-e34.
    1. Ngongo, P.B., Priddy, F.H., Park, H.H., Becker, J., Bender, B., Fast, P., Anzala, O., Mutua, G., Ruzagira, E., Kamali, A., Karita, E., Mugo, P., Chomba, E., Bekker, L., Roux, S.M., Nanvubya, A. and Mebrahtu, T. 2012. Developing standards of care for HIV prevention research in developing countries - a case study of 10 research centers in Eastern and Southen Africa. Aids Care, 24(10): 1277-1289.
    1. Ntsekhe, M., Matthews, K., Wolske, J., Badri, M., Wilkinson, K., Wilkinson, R.J., Sturrock, E.D. and Mayosi, B.M. 2012. Ac-SDKP (N-acetyl-seryl-aspartyl-lysyl-proline) and Galectin-3 levels in tuberculous pericaridal effusion: implications for pathogenesis and prevention of pericardial constriction. Heart, 98(17): 1326-1328.
    1. Ntsekhe, M., Mayosi, B.M. and Gumboo, T. 2012. Quantification of echodensities in tuberculous pericardial effusion using fractal geometry: a proof of concept study. Cardiovascular Ultrasound, 10:30.
    1. Ntsekhe, M., Wiysonge, C.S., Commerford, P.J. and Mayosi, B.M. 2012. The prevalence and outcome of effusive constrictive pericarditis: a sysematic review of the literature. Cardiovascular Journal of Africa, 23: 281-285.
    1. Ntusi, N., Badri, M., Khalfey, H., Whitelaw, A.C., Oliver, S.P., Piercy, J.L., Raine, R.I., Joubert, I. and Dheda, K. 2012. ICU-associated acinetobacter baumannii colonisation/infection in a high HIV-prevalence resource-poor setting. PLoS One, 7(12): e52452.
    1. Nyo, M.T.L., Schoeman, L., Sookhayi, R. and Mayosi, B.M. 2012. HIV infection, pulmonary arterial hypertension and pregnancy: a fatal triad. Cardiovascular Journal of Africa, 23(7): e4-e6.
    1. Okpechi, I.G., Ayodele, O., Jones, E., Duffield, M. and Swanepoel, C.R. 2012. Outcome of patients with membranous lupus nephritis in Cape Town South Africa. Nephrology Dialysis Transplantation, 27: 3509-3515.
    1. Okpechi, I.G., Rayner, B.L. and Swanepoel, C.R. 2012. Peritoneal dialysis in Cape Town, South Africa. Peritoneal Dialysis International, 32(3): 254-260.
    1. Okpechi, I.G., Swanepoel, C.R. and Rayner, B.L. 2012. Outcomes of rationing dialysis therapy in biopsy-proven end-stage renal disease in South Africa. Journal of Nephrology, 25(4): 551-557.
    1. Okpechi, I.G., Swanepoel, C.R., Tiffin, N., Duffield, M. and Rayner, B.L. 2012. Clinicopathological insights into lupus nephritis in South Africa: a study of 251 patients. Lupus, 21: 1017-1024.
    1. Oni, T., Tsekela, R., Kwaza, B., Manjezi, L., Bangani, N.M., Wilkinson, K., Coetzee, D.J. and Wilkinson, R.J. 2012. A recent HIV diagnosis is associated with non-completion of isoniazid preventive therapy in an HIV-infected cohort in Cape Town. PLoS One, 7(12): e52489.
    2. Oni, T., Gideon, H., Bangani, N.M., Tsekela, R., Seldon, R.R., Wood, K.A., Wilkinson, K., Goliath, R., Ottenhoff, T.H.M. and Wilkinson, R.J. 2012. Risk factors associated with indeterminate gamma interferon responses in the assessment of latent tuberculosis infection in a high incidence environment. Clinical and Vaccine Immunology, 19(8): 1243-1247.
    3. Oni, T., Gideon, H., Bangani, N.M., Tsekela, R., Seldon, R.R., Wood, K.A., Wilkinson, K., Goliath, R., Ottenhoff, T.H.M. and Wilkinson, R.J. 2012. Smoking, BCG and employment and the risk of tuberculosis infection in HIV-infected persons in South Africa. PLoS One, 7(10): e47072.
    4. Opie, L.H. 2012. Allopurinol for Heart Failure Novel Mechanism. Journal of the American College of Cardiology, 59(9): 809-812.
    5. Opie, L.H. 2012. Cardioprotection from metabolism to molecules to certainties. SAMJ South African Medical Journal, 102(6): 491-492.
    6. Oudijk, J.M., McIlleron, H., Mulenga, V., Chintu, C., Merry, C., Walker, A.S., Cook, A., Gibb, D.M. and Burger, D.M. 2012. Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment. Aids, 26(12): 1523-1528.
    7. Owen, P., Leisegang, F., Whitelaw, A.C., Simpson, J., Baker, S., Wurzner, R., Potter, P.C. and Orren, A. 2012. Complement component C5 and C6 mutation screening indicated in meningococcal disease in South Africa. SAMJ South African Medical Journal, 102(6): 525-527.
  • P - T

    1. Pandie, M., van Der Plas, H., Maartens, G. and Mendelson, M. 2012. The role of the infectious diseases unit at Groote Schuur Hospital in addressing South Africa's greatest burden of disease. SAMJ South African Medical Journal, 102(6): 528-531.
    2. Parker, W., Steyn, N., Levitt, N. and Lombard, C. 2012. Health promotion services for patients having non-communicable diseases: feedback from patients and health care providers in Cape Town, South Africa. BMC Public Health, 12:503.
    3. Pathai, S., Lawn, S.D. and Gilbert, C. 2012. Cytomegalovirus retinitis associated with HIV in resource-constrained settings: systematic screening and case detection. International Health, 4: 86-94.
    4. Pathai, S., Weiss, H., Lawn, S.D., Peto, T., D'Costa, L.M., Cook, C.D., Wong, T.Y. and Gilbert, C.E. 2012. Retinal arterioles narrow with increasing duration of anti-retroviral therapy in HIV Infection: a novel estimator of vascular risk in HIV? PLoS One, 7(12): e51405.
    5. Peer, N., Steyn, K., Lombard, C., Lambert, E.V., Vythilingum, B. and Levitt, N. 2012. Rising diabetes prevalence among urban-dwelling black South Africans. PLoS One, 7(9): e43336.
    6. Pepper, D.J., Marais, S., Bhaijee, F., Wilkinson, R.J., De Azevedo, V. and Meintjes, G. 2012. Assessment at antiretroviral clinics during TB treatment reduces loss to follow-up among HIV-infected patients.. PLoS One, 7(6): e37634.
    7. Peter, J., Cashmore, T., Meldau, R., Theron, G., Van Zyl Smit, R. and Dheda, K. 2012. Diagnostic accuracy of induced sputum LAM ELISA for tuberculosis diagnosis in sputum-scare patients. International Journal of Tuberculosis and Lung Disease, 16(8): 1108-1112.
    8. Peter, J., Theron, G., Muchinga, T., Govender, U. and Dheda, K. 2012. The diagnostic accuracy of urine-based xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce. PLoS One, 7(7): e39966.
    9. Peter, J., Theron, G., Van Zyl Smit, R., Haripersad, A., Mottay, L., Kraus, S., Binder, A.B., Meldau, R., Hardy, A. and Dheda, K. 2012. Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-Infected hospitlised patients. European Respiratory Journal, 40(5): 1211-1220.
    10. Petros, G. 2012. Use of a mixed methods approach to investigate the support needs of older caregivers to family members affected by HIV and AIDS in South Africa. Journal of Mixed Methods Research, 6(4): 275-293.
    11. Price, M.A., Rida, W., Mwangome, M., Mutua, G., Middelkoop, K., Roux, S.M., Okuku, H.S., Bekker, L., Anzala, O., Ngugi, E., Stevens, G., Chetty, P., Amornkul, P.N. and Sanders, E.J. 2012. Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth. Jaids-Journal of Acquired Immune Deficiency Syndromes, 59(2): 185-193.
    12. Rangaka, M.X., Gideon, H., Wilkinson, K., Pai, M., Mwansa-Kambafwile, J.R.M., Maartens, G., Glynn, J.R., Boulle, A.M., Fielding, K.L., Goliath, R., Mathee, S., Titus, R. and Wilkinson, R.J. 2012. Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms. European Respiratory Journal, 39(1): 163-171.
    13. Rangaka, M.X., Wilkinson, K., Glynn, J.R., Ling, D., Menzies, D., Mwansa-Kambafwile, J.R.M., Fielding, K.L., Wilkinson, R.J. and Pai, M. 2012. Predictive value of interferon- release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infectious Diseases, 12(1): 45-55.
    14. Rangaka, M.X., Wilkinson, R.J., Glynn, J.R., Boulle, A.M., Van Cutsem, G., Goliath, R., Mathee, S. and Maartens, G. 2012. Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for Intensified tuberculosis case finding in a South African HIV Clinic. Clinical Infectious Diseases, 55(12): 1698-1706.
    15. Rayner, B.L. 2012. Hypertension, chronic kidney disease, atrial fibrillation and the newer anticoagulants. South African Family Practice, 54(5): 418-419.
    16. Rayner, B.L., Ramesar, R.S., Steyn, K., Levitt, N.S., Lombard, C. and Charlton, K.E. 2012. G-protein-coupled receptor kinase 4 polymorphisms predict blood pressure response to dietary modification in black patients with mild-to-moderate hypertension. Journal of Human Hypertension, 26(0): 334-339.
    17. Reddy, S.P., Resnicow, K., James, S., Funani, I., Kambaran, N., Omardien, R., Masuka, M., Sewpaul, R., Vaughan, R.D. and Mbewu, A. 2012. Rapid increases in overweight and obesity among South African adolescents: comparison of data from the South African national youth risk behaviour survey in 2002 and 2008. American Journal of Public Health, 102(2): 262-268.
    18. Reid, E., Orrell, C., Stoloff, K. and Joska, J. 2012. Psychotropic prescribing in HIV. Southern African Journal of HIV medicine, 13(4): 188-194.
    19. Rezq, A., Basavarajaiah, S., Latib, A., Takagi, K., Hasegawa, T., Figini, F., Cioni, M., Franco, A., Montorfano, M., Chieffo, A., Maisano, F., Corvaja, N., Alfieri, O. and Colombo, A. 2012. Incidence, management, and outcomes of cardiac tamponade during transcatheter aortic valve implantation. JACC-Cardiovascular Interventions, 5(12): 1264-1272.
    20. Ritchie, P.L.M., van Lettow, M., Barnsley, J., Chan, A.K., Joshua, M., Martiniuk, A.L., Schull, M.J. and Zwarenstein, M. 2012. Evaluation of lay health worker's needs to effectively support anti-tuberculosis treatment adherence in Malawi. International Journal of Tuberculosis and Lung Disease, 16(11): 1492-1497.
    21. Robertson, B.D., Altmann, D., Barry 3rd, C.E., Bishai, B., Cole, S., Dick, T., Duncan, K., Dye, C., Ehrt, S., Esmail, H., Flynn, J., Hafner, R., Handley, G., Hanekom, W.A., Van Helden, P., Kaplan, G., Kaufmann, S.H.E., Kim, P., Lienhardt, C., Mizrahi, V., Rubin, E., Schnappinger, D., Sherman, D...R., Thole, J., Vandal, O., Walzl, G., Warner, D., Wilkinson, R.J. and Young, D.B. 2012. Detection and treatment of subclinical tuberculosis. Tuberculosis, 92: 447-452.
    22. Rotherham, L.S., Maserumule, M., Dheda, K., Theron, J. and Khati, M. 2012. Selection and application of ssDNA aptamers to detect active TB from sputum samples. PLoS One, 7(10): e46862.
    23. Sarkar, R., Lenders, L., Wilkinson, K., Wilkinson, R.J. and Nicol, M.P. 2012. Modern lineages of mycobacterium tuberculosis exhibit lineage-specific patterns of growth and cytokine induction in human monocyte-derived macrophages. PLoS One, 7(8): e43170.
    24. Schutz, C., Ismail, Z., Proxenos, C.J., Marais, S., Burton, R., Kenyon, C., Maartens, G., Wilkinson, R.J. and Meintjes, G. 2012. Burden of antituberculosis and antiretroviral drug-induced liver injury at a secondary hospital in South Africa. SAMJ South African Medical Journal, 102(6): 506-511.
    25. Schwartz, P.J. 2012. Automatic modulation for chronic heart failure: a new kid on the block? . European Journal Of Heart Failure, 14: 1316-1318.
    26. Schwartz, P.J. 2012. Introduction to the arrhythmogenic disorders of genetic origin series. Circulation-Arrhythmia and Electrophysiology, 5: 604-605.
    27. Schwartz, P.J., Crotti, L. and Insolia, R. 2012. Long-QT syndrome: from genetics to management. Circulation-Arrhythmia and Electrophysiology, 5: 868-877.
    28. Seddon, J.A., Hesseling, A.C., Marais, B.J., McIlleron, H., Peloquin, C.A., Donald, P.R. and Schaaf, H. 2012. Paediatric use of second-line anti-tuberculosis agents: a review. Tuberculosis, 92: 9-17.
    29. Seedat, Y. and Rayner, B.L. 2012. South African hypertension guideline 2011. SAMJ South African Medical Journal, 102(1): 60-84.
    30. Selker, H.P., Beshansky, J.R., Sheehan, P.R., Massaro, J.M., Griffith, J.L., D'Agostino, R.B., Ruthazer, R., Atkins, J.M., Sayah, A., Levy, M.K., Richards, M.E., Aufderheide, T.P., Braude, D.A., Pirrallo, R.G., Doyle, D.D., Franscone, R.J., Kosiak, D.J., Leaming, J.M., Van Gelder, C.M., Walter, G.-P., Wayne, M.A., Woorlard, R.H., Opie, L.H., Rackley, C.E., Apstein, C.S. and Udelson, J.E. 2012. Out-of-hospital administration intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes. Jama-Journal of the American Medical Association, 307(18): 1925-1933.
    31. Selker, H.P., Beshansky, J.R., Griffith, J.L., D'Agostino, R.B., Massaro, J.M., Udelson, J.E., Rashba, E.J., Ruthazer, R., Sheenan, P.R., Desvigne-Nickens, P., Rosenberg, Y.D., Atkins, J.M., Sayah, A., Aufderheide, T.P., Rackley, C.E., Opie, L.H., Lambrew, C., Cobb, L.A., Macleod, B., Ingwall, J.S., Zalenski, R.J. and Apstein, C.S. 2012. Study design for the immediate mycordial metabolic enhancement during initial assessment and treatment in emergency care (immediate) trial: a double-blind randomized controlled trial of intravenous glucose, insulen, and potassium for acute coronary syndromes in emergency medical services. American Heart Journal, 163: 315-322.
    32. Setshedi, M., Epstein, D., Winter, T., Myer, L., Watermeyer, G. and Hift, R. 2012. Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study. Journal of Gastroenterology and Hepatology, 27: 385-389.
    33. Shaikh, M.M., Kruger, H.G., Bodenstein, J., Smith, P.J. and du Toit, K. 2012. Anti-inflammatory activities of selected synthetic homoisoflavanones. Natural Product Research, 26(16): 1473-1482.
    34. Shannon, J., Latib, A. and Colombo, A. 2012. Iatrogenic perforation of the medial circumflex artery following femoral venous cannulation for tanscatheter aortic valve replacement, presenting with retroperitoneal hematoma and successfully managed by percutaneous embolization and coiling. Catheterization and Cardiovascular Interventions, 80: 1002-1006.
    35. Skelton, M., Kew, M.C. and Kramvis, A. 2012. Distinct mutant hepatitis B virus genomes, with alterations in all four open reading frames, in a single South African hepatocellular carcinoma patient. Virus Research, 163(1): 59-65.
    36. Skolimowska, K., Rangaka, M.X., Meintjes, G., Pepper, D.J., Seldon, R.R., Matthews, K., Wilkinson, R.J. and Wilkinson, K. 2012. Altered Ratio of IFN-y/IL-10 in patients with drug resistant mycobacterium tuberculosis and HIV-tuberculosis immune reconstitution inflammatory syndrome. PLoS One, 7(10): e46481.
    37. Sliwa, K. and Zilla, P. 2012. Rheumatic heart disease: the tip of the iceberg. Circulation, 125: 3060-3062.
    38. Sliwa, K., Carrington, M., Becker, A., Thienemann, F., Ntsekhe, M. and Stewart, S. 2012. Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the heart of Soweto study cohort. European Heart Journal, 33: 866-874.
    39. Sliwa, K., Lyons, J.G., Carrington, M., Lecour, S., Marais, A.D., Raal, D. and Stewart, S. 2012. Different lipid profiles according to ethnicity in the heart of Soweto study cohort of de novo presentations of heart disease. Cardiovascular Journal of Africa, 23(7): 389-395.
    40. Smythe, W., Khandelwal, A., Merle, C., Rustomjee, R., Gninafon, M., Bocar Lo, M., Sow, O.B., Olliaro, P., Lienhardt, C., Horton, J., Smith, P.J., McIlleron, H. and Simonsson, U. 2012. A semimechanistic pharmacokinetic-enzyme turnover model for rifampin autoinduction in adult tuberculosis patients. Antimicrobial Agents and Chemotherapy, 56(4): 2091-2098.
    41. Somers, S., Frias, M., Lacerda, L., Opie, L.H. and Lecour, S. 2012. Interplay between safe and risk pathways in sphingosine-1-phosphate-induced cardioprotection. Cardiovascular Drugs and Therapy, 26: 227-237.
    42. Stanley, A., Candy, S., Levin, C. and Heckmann, J.M. 2012. The complexity of HIV vasculopathy. SAMJ South African Medical Journal, 102(6): 474-476.
    43. Stewart, S., Carrington, M., Pretorius, S., Okechukwu, O.S., Blauwet, L., Antras-Ferry, J. and Sliwa, K. 2012. Elevated risk factors but low burden of heart disease in urban African primary care patients: a fundamental role for primary prevention. International Journal of Cardiology, 158: 205-210.
    44. Stinson, K., Boulle, A.M., Smith, P.J., Stringer, E.M., Stringer, J.S.A. and Coetzee, D.J. 2012. Coverage of the prevention of mother-to-child transmission program in the Western Cape, South Africa using cord blood surveillance. Jaids-Journal of Acquired Immune Deficiency Syndromes, 60(2): 199-204.
    45. Streicher, E.M., Bergval, I., Dheda, K., Bottger, E.C., Gey van Pittius, N.C., Bosman, M., Coetzee, G., Anthony, R.M., Van Helden, P., Victor, T. and Warren, R.M. 2012. Mycobacterium tuberculosis population structure determines the outcome of genetic - based second - line drug resistance testing. Antimicrobial Agents and Chemotherapy, 56(5): 2420-2427.
    46. Stuart-Clark, H., Vorajee, N., Zuma, S., van Niekerk, L., Burch, V.C., Raubenheimer, P.J. and Peter, J. 2012. Twelve-month outcomes of patients admitted to the acute general medical service at Groote Schuur Hospital. SAMJ South African Medical Journal, 102(6): 549-553.
    47. Sunpath, H., Edwin, C., Chelin, N., Nadesan, S., Maharaj, R., Moosa, M.-Y.S., Smeaton, L., Court, R.G., Knight, S.E., Gwyther, E. and Murphy, R. 2012. Operationalizing early antiretroviral therapy in HIV-infected in-patients with opportunistic infections including tuberculosis. International Journal of Tuberculosis and Lung Disease, 16(7): 917-923.
    48. Suthar, A.B., Lawn, S.D., del Amo, J., getahun, H., Dye, C., Sculier, D., Sterling, T.R., Chaisson, R., Williams, B., Harries, A.D. and Granich, R. 2012. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS One, 9(7): e1001270.
    49. Svensson, E., Van der Walt, J.-S., Barnes, K.I., Cohen, K., Kredo, T., Huitema, A., Nachega, J.B., Karlsson, M.O. and Denti, P. 2012. Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics. British Journal of Pharmacology, 74(3): 465-476.
    50. Swanepoel, C.R., Wearne, N., Duffield, M. and Okpechi, I.G. 2012. The Evolution of our knowledge of HIV-associated kidney disease in Africa. American Journal of Kidney Diseases, 60(4): 668-678.
    51. Swart, M., Whitehorn, H., Ren, Y., Smith, P.J., Ramesar, R.S. and Dandara, C. 2012. PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients. BMC Medical Genetics, 13:112.
    52. Tacon, C., Guantai, E.M., Smith, P.J. and Chibale, K. 2012. Synthesis, biological evaluation and mechanistic studies of totarol amino alcohol derivatives as potential antimalarial agents. Bioorganic & Medicinal Chemistry, 20: 893-902.
    53. Takagi, K., Ielasi, A., Shannon, J., Latib, A., Godino, C., Davidavicius, G., Mussardo, M., Ferrarello, S., Figini, F., Carlino, M., Montorfano, M., Chieffo, A., Nakamura, S. and Colombo, A. 2012. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem. Circulation-Cardiovascular Interventions, 5: 491-498.
    54. Tan, W.C., Vollmer, W.M., Lamprecht, B., Mannino, D.M., Nizankowska-Mogilnicka, E., Mejza, F., Gislason, T., Burney, P.G.J., Buist, S.A., Bateman, E.D., Jithoo, A. and Johannisen, C.F. 2012. Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study. Thorax, 67: 718-726.
    55. Testa, L., Agnifili, M., Latini, R.A., Mattioli, R., Lanotte, S., De Marco F, F., Oreglia, J., Latib, A., Pizzocri, S., Laudisa, M.L., Brambilla, N. and Bedogni, F. 2012. Adjusted indirect comparison of new oral anticoagulants for stroke prevention in atrial fibrillation. QJM-An International Journal of Medicine, 105: 949-957.
    56. Thelingwani, R.S., Dhansay, K., Smith, P., Chibale, K. and Masimirembwa, C.M. 2012. Potent inhibition of CYP1A2 by frutinone A, an active ingredient of the broad spectrum antimicrobial herbal extract from P.fruticosa. Xenobiotica, 42(10): 989-1000.
    57. Theron, G., Peter, J., Lenders, L., Van Zyl Smit, R., Meldau, R., Govender, U. and Dheda, K. 2012. Correlation of mycobacterium tuberculosis specific and non-specific quantitative th1 t-cell responses with bacillary load in a high burden setting. PLoS One, 7(5): e37436.
    58. Theron, G., Pooran, A., Peter, J., Van Zyl Smit, R., Mishra, H., Meldau, R., Calligaro, G., Allwood, B.W., Sharma, S.K., Dawson, R. and Dheda, K. 2012. Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting. European Respiratory Journal, 40(1): 161-168.
    59. Theron, G., Pinto, L., Peter, J., Mishra, H.K., Mishra, H., Van Zyl Smit, R., Sharma, S.K. and Dheda, K. 2012. The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients. Clinical Infectious Diseases, 54(3): 384-388.
    60. Thomas, A., Orren, A., Connaughton, J., Feighery, C., Morgan, B.P. and Roberts, A. 2012. Characterization of a large genomic deletion in four irish families with C7 deficiency. Molecular Immunology, 50: 57-59.
    61. Thompson, M.A., Mugavero, M.J., Amico, R., Cargill, V.A., Chang, L., Gross, R., Orrell, C., Altice, F.L., Bangsberge, D.R., Bartlett, J.G., Beckwith, C.G., Dowshen, N., Gordon, C.M., Horn, T., Kumar, P., Scott, J.D., Stirratt, M.J., Remien, R.H., Simoni, J.M. and Nachega, J. 2012. Guidelines for improving entry into and retention in care and antiretroviral adherence for person's with HIV: evidence based recommendations from an international association of physians in AIDS care panel. Annals of Internal Medicine, 156: 817-833.
    62. Tibazarwa, K., Lee, G., Mayosi, B.M., Carrington, M., Stewart, S. and Sliwa, K. 2012. The 12-lead ECG in peripartum cardiomyopathy. Cardiovascular Journal of Africa, 23(6): 322-329.
    63. To, T., Stanojevic, S., Moores, G., Gershon, A., Bateman, E.D., Cruz, A.A. and Boulet, L.-P. 2012. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health, 12:204.
    64. Tod, B., Carrara, H., Levin, M. and Todd, G. 2012. Dermatological manifestations of measles infection in hospitalised paediatric patients observed in the 2009 - 2011 Western Cape epidemic. SAMJ South African Medical Journal, 102(6): 356-359.
  • U - Z

    1. Van der Straten, A., Montgomery, E.T., Cheng, H., Wegner, L., Masenga, G., von Mollendorf, C., Bekker, L., Ganesh, S., Young, K., Romano, J., Nel, A. and Woodsong, C. 2012. High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women. AIDS and Behavior, 16: 1775-1786.
    2. Van Dieren, S., Beulens, J., Kengne, A.P., Peelen, L.M., Rutten, G., Woodward, M., van der Schouw, Y.T. and Moons, K.G.M. 2012. Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review. Heart, 98: 360-369.
    3. Van Dieren, S., Czernichow, S., Chalmers, J., Kengne, A.P., de Galan, B.E., Poulter, N., Woodward, M., Beulens, J., Grobbee, D.E., van der Schouw, Y.T. and Zoungas, S. 2012. Weight changes and their predictors amongst the 11 140 patients with type 2 diabetes in the advance trial. Diabetes Obesity & Metabolism, 14: 464-469.
    4. Van Heerden, L., Cloete, T.T., Breytenbach, W.J., De Kock, C., Smith, P.J., Breytenbach, J.C and N'Da, D.D. 2012. Synthesis and in vitro antimalarial activity of series of bisquinoline and bispyrrolo [1,2a] quinoxaline compounds. European Journal of Medicinal Chemistry, 55: 335-345.
    5. Van Niekerk, L., Scribante, L. and Raubenheimer, P.J. 2012. Suicidal ideation and attempt among South African medical students. SAMJ South African Medical Journal, 102(6): 372-373.
    6. Van Schalkwyk, S., Bezuidenhout, J., Burch, V.C., Clarke, M., Conradie, H., van Heerden, B. and de Villiers, M. 2012. Developing an educational research framework for evaluating rural training of health professionals: a case for innovation. Medical Teacher, 34: 1064-1069.
    7. Visser, M.M.E., Stead, M., Walzl, G., Warren, R.M., Schomaker, M., Grewal, H.M.S., Swart, E.C. and Maartens, G. 2012. Baseline predictors of sputum culture conversion in pulmonary tuberculosis: importance of cavities, smoking, time to detection and w-beijing genotype. PLoS One, 7(1): e29588.
    8. Vogel, J., Nel, D., Chapman, L. and Burch, V.C. 2012. The Game: student 'teaching' objective structured clinical examinations in South Africa. Medical Education, 46: 501-527.
    9. Vordermeier, H., Hewinson, R.G., Wilkinson, R.J., Wilkinson, K., Gideon, H., Young, D.B. and Sampson, S.L. 2012. Conserved immune recognition hierarchy of mycobacterial PE/PPE proteins during Infection in natural hosts. PLoS One, 7(8): e40890.
    10. Vos, T., Flaxman, A., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J.A., Abdalla, S., Aboyans, V., Matzopoulos, R. and Mayosi, B.M. 2012. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet, 380 (December): 2163-2196.
    11. Walensky, R.P., Park, J.-E., Wood, R., Freedberg, K.A., Scott, C.A., Bekker, L., Losina, E., Mayer, K.H., Seage III, G.R. and Paltiel, A.D. 2012. The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. Clinical Infectious Diseases, 54(10): 1504-1513.
    12. Walenta, K., Schwarz, V., Schirmer, S.H., Kindermann, I., Friedrich, E.B., Solomayer, E.F., Sliwa, K., Labidi, S., Hilfiker-Kleiner, D. and Bohm, M. 2012. Circulating microparticles as indicators of perpartum cardiomyopathy. European Heart Journal, 33: 1469-1479.
    13. Walker, N.F., O Clark, S., Oni, T., Andreu, N., Tezera, L., Singh, S., Saraiva, L., Pedersen, B., Kelly, D.L., Tree, J.A., D' Armiento, J., Meintjes, G., Mauri, M.A., Williams, A., Wilkinson, R.J., Friedland, J. and Elkington, P.T.G. 2012. Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases. American Journal of Respiratory and Critical Care Medicine, 185(9): 989-997.
    14. Wallis, L., Papathanasopolous, M.A., Fox, M.P., Conradie, F., Ive, P., Orrell, C., Zeinecker, J., Sanne, I., Wood, R., McIntyre, J., Stevens, W.S., The CIPRA SA project 1 study team, C., Badal-Faesen, S., Botile, M., Choonilal, N., Gelant, J. and Grab, J. 2012. Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy. Antiviral Therapy, 17: 313-320.
    15. Wandeler, G., Keiser, O., Mulenga, L., Hoffmann, C.J., Wood, R., Chaweza, T., Brennan, A., Prozesky, H., Garone, D., Giddy, J., Chimbetete, C., Boulle, A.M. and Egger, M. 2012. Tenofovir in Second-Line ART in Zambia and South Africa: collaborative analysis of cohort studies. Jaids-Journal Of Acquired Immune Deficiency Syndromes, 61(1): 41-48.
    16. Wasserman, S. and Bryer, A. 2012. Early outcomes of thrombolysis for acute ischaemic stroke in a South African tertiary care centre. SAMJ South African Medical Journal, 102(6): 541-544.
    17. Watkins, D.A., Sebitloane, M., Engel, M.E. and Mayosi, B.M. 2012. The burden of antenatal heart disease in South Africa: a systematic review. BMC Cardiovascular Disorders, 12:23.
    18. Wearne, N., Swanepoel, C.R., Boulle, A.M., Duffield, M. and Rayner, B.L. 2012. The spectrum of renal histologies seen in HIV with outcomes prognostic indicators and clinical correlations. Nephrology Dialysis Transplantation, 27: 4109-4118.
    19. Wilkinson, K., Meintjes, G., Seldon, R.R., Goliath, R. and Wilkinson, R.J. 2012. Immunological characterisation of an unmasking TB-IRIS case. SAMJ South African Medical Journal, 102(6): 512-517.
    20. Williamson, A.-L., Rybicki, E.P., Shephard, E.G., Gray, G., Bekker, L., Downing, K.J. and Williamson, C. 2012. South African HIV-1 vaccine candidates the journey from the bench to clinical trials. SAMJ South African Medical Journal, 102(6): 452-455.
    21. Wiysonge, C.S., Bradley, H., Volmink, J., Mayosi, B.M., Mbewu, A. and Opie, L.H. 2012. Beta-blockers for hypertension. Cochrane Database of Systematic Reviews, 11: 1-80.
    22. Wonkam, A., Ponde, C., Nicholson, N., Fieggen, K., Ramesar, R.S. and Davidson, A. 2012. The burden of sickle cell disease in Cape Town. SAMJ South African Medical Journal, 102(9): 752-754.
    23. Wood, R., Racow, K., Bekker, L., Morrow, C.D., Middelkoop, K., Mark, D. and Lawn, S.D. 2012. Indoor social networks in a South African township: potential contribution of location to tuberculosis transmission. PLoS One, 7(6): e39246.
    24. Wood, R., Racow, K., Bekker, L., Middelkoop, K., Vogt, M.C., Kreiswirth, B. and Lawn, S.D. 2012. Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria. BMC Infectious Diseases, 12:47.
    25. Yone, E.W.P., Kuaban, C. and Kengne, A.P. 2012. HIV testing, HIV status and outcomes of treatment for tuberculosis in a major diagnosis and treatment centre in Yaounde, Cameroon: a retrospective cohort study. BMC Infectious Diseases, 12:190.
    26. Zawaira, A., Pooran, A., Barichievy, S. and Chopera, D. 2012. A discussion of molecular biology methods for protein engineering. Molecular Biotechnology, 51(1): 67-102.
    27. Zhang, C., Denti, P., Van der Walt, J.-S., Ren, Y., Smith, P.J., Karlsson, M.O. and McIlleron, H. 2012. Population pharmacokinetic model for adherence evaluation using lamivudine concentration monitoring. Therapeutic Drug Monitoring, 34(4): 481-484.
    28. Zhang, C., McIlleron, H., Ren, Y., Van der Walt, J.-S., Karlsson, M.O., Simonsson, U. and Denti, P. 2012. Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin - based antitubercular treatment in HIV-infected children. Antiviral Therapy, 17: 25-33.
    29. Zuhlke, L., Myer, L. and Mayosi, B.M. 2012. The promise of computer-assisted auscultation in screening for structural heart disease and clinical teaching. Cardiovascular Journal of Africa, 23(7): 405-408.
    30. Zumla, A., Abubaker, I., Raviglione, M., Hoelscher, M., Ditiu, L., McHugh, T., B Squire, B., Cox, H., Ford, N., McNerney, R., Marais, B., Grobusch, M.P., Lawn, S.D., Migliori, G.B., Mwaba, P., O'Grady, J., Pletschette, M., Ramsay, A., Chakaya, J., Schito, M., Swaminathan, S., Memish, Z., Maeurer, M. and Atun, R. 2012. Drug-resistant tuberculosis-current dilemmas, unanswered questions, challenges, and priority needs. Journal of Infectious Diseases, suppl 2(205): S228 -S240.
    31. Zvada, S.P., Denti, P., Geldenhuys, H.D., Meredith, S.A., Van As, D., Hatherill, M., Hanekom, W.A., Wiesner, L., Simonsson, U., Jindani, A., Harrison, T. and McIlleron, H. 2012. Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high-dose rifapentine. Antimicrobial Agents and Chemotherapy, 56(8): 4471-4473.


Peer-reviewed Journals (not DoE Accredited)

  • A - E

    1. Airoldi F, Faglia E, Losa S, Tavano D, Latib A, Lanza G, Clerici G. Antegrade approach for percutaneous interventions of ostial superficial femoral artery: outcomes from a prospective series of diabetic patients presenting with critical limb ischemia. Cardiovasc Revasc Med. 2012 Jan-Feb;13(1):20-4.
    2. Colombo, A. and Latib, A. 2012. Left Bundle Branch Block After Transcatheter Aortic Valve Implantation: Inconsequential or a Clinically Important Endpoint? Journal of the American College of Cardiology, 60(18):
    3. Colombo A, Latib A. J Am Coll Cardiol. 2012. Left bundle branch block after transcatheter aortic valve implantation: inconsequential or a clinically important endpoint? Oct 30;60(18): doi: 10.1016/j.jacc.2012.07.034. Epub 2012 Oct 3.
    4. Colombo A, Latib A. 2012. Disease progression is as important as culprit lesion treatment.
    5. J Am Coll Cardiol.59(9):800-1.
    6. Draper, C.E., Moller, N.A., Aubin, L.A., Edelstein, G. and Weiss, R. 2012. Developing a standardised patient programme in a primary healthcare curriculum: a needs analysis. African Journal of Health Professions Education, 4(2): 97-101.
  • F - J

    1. Gottschalk, S., Warner, C., Burch, V.C. and Wallis, L.A. 2012. Warning scores in triage-Is there any point? African Journal of Emergency Medicine (AfJEM), 1: 103-107.
  • K - O

    1. Kranze, K., Govindasamy, D., Ford, N., Johnston, V., and Lawn, S.D. 2012. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. Journal of the International AIDS Society, 15:17383.
    2. Lelasi A, Latib A, Montorfano M, Torracca L, Colombo A. Percutaneous treatment of iatrogenic left main ostial stenosis: after a Bentall operation. Tex Heart Inst J. 2012;39(1):144-5.
    3. Lowe, D.M., Redford. P.S.., Wilkinson, R.J., O’Garra, A. and Martineau, A.R. 2012. Neutrophils in tuberculosis: friend or foe? Trends in Immunology, 33(1):14-25.
    4. Meintjes, G., Scriven, J., and Marais, S. 2012. Management of the Immune Reconstitution Inflammatory Syndrome. Curr HIV/AIDS Rep, 9:238-250
    5. Muller, E., Barday, Z., Mccurdie, F. and Kahn, D. 2012. Deceased donor organ transplantation: a single center experience from Cape Town, South Africa. African Journal of Urology, 18: 167-169.
  • P - T

    1. Sinxadi, P., McIlleron, H., Dave, J.A., Smith, P.J., Levitt, N. and Maartens, G. 2012. Association of lopinavir concentrations with plasma lipid or glucose concentrations in HIV-infected South Africans: a cross sectional study. AIDS research and therapy, 9(32): 1-6.
    2. Swart, M., Ren, Y., Smith, P.J. and Dandara, C. 2012. ABCB1 4036A>G and 1236C>T polymorphisms affect plasma efavirenz levels in South African HIV/AIDS patients. Frontiers in Genetics, 3:326.
    3. Syed FF, Ntsekhe M, Wiysonge CS, Badri M, Oh JK, Mayosi BM. Atrial fibrillation as a consequence of tuberculous pericardial effusion. Int J Cardiol. 2012 Jun 28; 158(1):152-4.
    4. Rayner BL. The young hypertensive patient. SA Family Practice 2012; 54: S29-S30.
    5. Pefura Yone, E.W., and Kengne, A.P. 2012. Clinical utility and consumer considerations for the use of once-daily nevirapine extended release for HIV infection treatment. HIV/AIDS – Research and Palliative Care, 4: 181 – 184.
    6. Rayner BL. The Abridged South African Hypertension Guideline 2011. SA Family Practice 2012; 54: S4-S8
  • U - Z